Antibody that targets inflammation has been found to enhance preterm birth outcomes and guard against obesity-related liver disease.

Published Date: 28 Jun 2023

Preterm births and fatty liver disease are unrelated conditions that currently have few effective treatments; however, two new studies suggest that targeting a master-regulator of inflammation with a monoclonal antibody may help.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Scientists Employ Technology to Identify Plagiarism and Forgeries in Published Studies.

2.

GuCS: Genitourinary Cancers Symposium

3.

Obesity-associated cancers tripled nationwide over past two decades

4.

A new mechanism of radioresistance formation demonstrated in lung adenocarcinoma

5.

EGFR Inhibitors for Lung Cancer Tied to Increased Keratitis Risk.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot